Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about disclosure

17 Jun 2024 Evaluate
Alembic Pharmaceuticals has informed that the company has received the USFDA Final approval for Icatibant Injection 30 mg/3mL (10 mg/mL) Single dose prefilled syringe. This is the first peptide product approval from the USFDA received by the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..